- 8301. cyclization
- [chemical reaction that causes parts of a molecule to join so that a ring of atoms is formed within the molecule. ( CSP )] (UMLS (CSP) C0010546) =Natural Phenomenon or Process =chemical reaction;
=Diels Alder reaction;
| - 8351. Cyclophosphamide/Dexamethasone/Doxorubicin
- (UMLS (NCI) C1134563) =Therapeutic or Preventive Procedure ;
|
- 8302. CYCLIZINE
- [A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935) ( MSH )] (UMLS (NCI) C0010547) =Organic Chemical; Pharmacologic Substance ;
=Piperazines;
[CN550] ANTIVERTIGO AGENTS =Cyclizine Lactate;
CYCLIZINE HYDROCHLORIDE;
Cyclizine Lactate;
CYCLIZINE HYDROCHLORIDE | - 8352. Cyclophosphamide/Dexamethasone/Doxorubicin/Leucovorin Calcium/Methotrexate/Vincristine
- (UMLS (NCI) C1134642) =Therapeutic or Preventive Procedure
|
- 8303. Cyclizine Lactate
- (UMLS (NCI) C0304305) =Organic Chemical; Pharmacologic Substance ;
=CYCLIZINE;
=CYCLIZINE LACTATE 50 MG/ML | - 8353. Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vinblastine
- (UMLS (NCI) C0935717) =Therapeutic or Preventive Procedure
|
- 8304. Cyclo((S)-gamma-oxo-L-alpha-aminooxiraneoctanoyl-L-phenylalanyl-L-phenylalanyl-D-2-piperidinecarbonyl)
- [An epoxide-containing cyclotetrapeptide with antitumor activity. It is an irreversible inhibitor of histone deacetylase. ( NCI )] (UMLS (NCI) C0084839) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 8354. Cyclophosphamide/Dexamethasone/Doxorubicin/Rituximab/Vincristine
- (UMLS (NCI) C1134697) =Therapeutic or Preventive Procedure ;
|
- 8305. Cyclo-Prostin
- [The sodium salt form of epoprostenol, a synthetic prostacyclin, a member of the family of prostaglandins, with vasodilatory and anticoagulant activity. Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation. This agent also inhibits platelet aggregation by antagonizing platelet glycoprotein (GP) IIb/IIIa receptors, thereby preventing thrombus formation. ( NCI )] (UMLS (NCI) C0354594) =Eicosanoid; Pharmacologic Substance =EPOPROSTENOL;
=EPOPROSTENOL SODIUM 1.5 MG;
EPOPROSTENOL SODIUM 0.5 MG;
| - 8355. Cyclophosphamide/Dexamethasone/Etoposide/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine
- (UMLS (NCI) C1134461) =Therapeutic or Preventive Procedure
|
- 8306. cycloaddition
- [ ] (UMLS (CSP) C0598128) =Phenomenon or Process
| - 8356. Cyclophosphamide/Dexamethasone/Mitoxantrone
- (UMLS (NCI) C0879544) =Therapeutic or Preventive Procedure ;
|
- 8307. cycloalkene
- [cyclic unsaturated hydrocarbon having at least one carbon-carbon double bond in the ring. ( CSP )] (UMLS (CSP) C0576732) =Organic Chemical =cyclic compound;
=benzene;
biphenyl compound;
toluene | - 8357. Cyclophosphamide/Dexrazoxane/Doxorubicin
- (UMLS (NCI) C0935845) =Therapeutic or Preventive Procedure
|
- 8308. CYCLOBENZAPRINE
- [A centrally acting skeletal muscle relaxant with antidepressant activity. The exact mechanism of action of cyclobenzaprine has not been fully determined, but this drug seems to primarily act at the brain stem to reduce tonic somatic motor activity, influencing both gamma and alpha motor neurons leading to a reduction in muscle spasms. ( NCI )] (UMLS (NCI) C0056732) =Organic Chemical; Pharmacologic Substance ;
=amitriptyline;
[MS200] SKELETAL MUSCLE RELAXANTS =10,11delta-Amitriptyline Hydrochloride | - 8358. Cyclophosphamide/Dexrazoxane/Doxorubicin/Oblimersen
- (UMLS (NCI) C1134674) =Therapeutic or Preventive Procedure
|
- 8309. Cyclobutane Pyrimidine Dimer
- [covalently linked adjacent pyrimidine bases (usually thymidine) on a strand of DNA produced by UV light or other radiation; the mutation blocks both transcription and replication until excised and repaired. ( CSP )] (UMLS (NCI) C0034286) =Nucleic Acid, Nucleoside, or Nucleotide ;
=DNA damage;
| - 8359. Cyclophosphamide/Docetaxel
- (UMLS (NCI) C0935668) Docetaxel/Cyclophosphamide;
=Therapeutic or Preventive Procedure |
- 8310. Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)-, Hydrochloride
- [The hydrochloride salt form of sibutramine, a phenethylamine derivative with appetite depressant property. Sibutramine hydrochloride metabolites M1 and M2 competitively inhibit the reuptake of norepinephrine, serotonin, and to a lesser degree dopamine by pre-synaptic nerve terminals, thereby promoting a sense of satiety, leading to a decrease in calorie intake, and possibly an increase in resting metabolic rate. This agent does not exhibit anticholinergic or antihistaminic effects. ( NCI )] (UMLS (NCI) C0142278) =Organic Chemical; Pharmacologic Substance =sibutramine;
=SIBUTRAMINE HYDROCHLORIDE 15 MG;
SIBUTRAMINE HYDROCHLORIDE 10 MG;
SIBUTRAMINE HYDROCHLORIDE 5 MG | - 8360. Cyclophosphamide/Doxorubicin/Epratuzumab/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C1327943) =Therapeutic or Preventive Procedure; ;
|
- 8311. CYCLOCRYOTHERAPY
- [ ] (UMLS (ICD9CM) C0197666) =Therapeutic or Preventive Procedure
| - 8361. Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C1327899) =Therapeutic or Preventive Procedure ;
|
- 8312. cyclodextrin
- [compound containing six or more D-glucose units joined through 1,4-alpha linkages to form a ring; used as complexing agents and in enzymology. ( CSP )] (UMLS (CSP) C0010558) =Carbohydrate; Biologically Active Substance ;
=glucan;
| - 8362. Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Vincristine
- (UMLS (NCI) C0879288) =Therapeutic or Preventive Procedure
|
- 8313. cyclodialysis
- [ ] (UMLS (CSP) C0197526) =Therapeutic or Preventive Procedure
| - 8363. Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C0879421) =Therapeutic or Preventive Procedure
|
- 8314. CYCLODIATHERMY
- [ ] (UMLS (ICD9CM) C1261306) =Therapeutic or Preventive Procedure
| - 8364. Cyclophosphamide/Doxorubicin/Etoposide/Rituximab/Vincristine
- (UMLS (NCI) C0935756) =Therapeutic or Preventive Procedure
|
- 8315. Cyclodisone
- [A cyclic sulfonate ester with potential antineoplastic activity. As an alkylating agent, clyclodisone induces the formation of DNA interstrand crosslinks, DNA strand breaks, and alkali-labile lesions in the DNA of some tumor cell lines. Alkylating agents exert cytotoxic and chemotherapeutic effects by transferring alkyl groups to DNA, thereby damaging DNA and interfering with DNA synthesis and cell division. (NCI04) ( NCI )] (UMLS (NCI) C0056746) =Organic Chemical; Pharmacologic Substance ;
| - 8365. Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C1134550) =Therapeutic or Preventive Procedure ;
|
- 8316. Cyclododecadepespipeptide Neutral Ionophore
- [A cyclic depsipeptide isolated from the bacterium Streptomyces fulvissimus. As a potassium-specific ionophore, mould element causes loss of mitochondrial membrane potential, thereby initiating cellular apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C0042287) =Amino Acid, Peptide, or Protein; Antibiotic ;
| - 8366. Cyclophosphamide/Doxorubicin/Iodine I 131 Tositumomab/Prednisone/Vincristine
- (UMLS (NCI) C0935736) =Therapeutic or Preventive Procedure
|
- 8317. Cyclodol
- (UMLS (NCI) C0701016) =Organic Chemical; Pharmacologic Substance ;
| - 8367. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Rituximab/Vincristine
- (UMLS (NCI) C1327931) =Therapeutic or Preventive Procedure; ;
|
- 8318. cycloheptane
- [ ] (UMLS (CSP) C0178579) =Organic Chemical =cyclic compound;
=amitriptyline;
(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide;
cyproheptadine;
NORTRIPTYLINE;
DIZOCILPINE;
| - 8368. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Vincristine
- (UMLS (NCI) C1327930) =Therapeutic or Preventive Procedure; ;
|
- 8319. cyclohexadiene
- [ ] (UMLS (CSP) C0526078) =Organic Chemical
| - 8369. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C0935895) =Therapeutic or Preventive Procedure
|
- 8320. cyclohexadienone
- [ ] (UMLS (CSP) C0598257) =Organic Chemical
| - 8370. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Vincristine
- (UMLS (NCI) C0935894) =Therapeutic or Preventive Procedure
|
- 8321. cyclohexane
- [group of alicyclic hydrocarbons with the general formula R-C6H11. ( CSP )] (UMLS (CSP) C0010568) =Organic Chemical ;
=Cycloparaffins;
cyclic compound =1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol;
Cyclohexanecarboxylic Acids;
Cyclohexanols;
KETAMINE;
A 4166;
| - 8371. Cyclophosphamide/Doxorubicin/Oblimersen/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C1328045) =Therapeutic or Preventive Procedure ;
|
- 8322. cyclohexane carboxylate
- [ ] (UMLS (CSP) C0920449) =Organic Chemical
| - 8372. Cyclophosphamide/Doxorubicin/Pegfilgrastim
- (UMLS (NCI) C1328069) =Therapeutic or Preventive Procedure; ;
|
- 8323. cyclohexane/cyclohexene carboxylate
- [ ] (UMLS (CSP) C0178580) =Organic Chemical =cyclic acid;
=shikimate;
| - 8373. Cyclophosphamide/Doxorubicin/Prednisolone/Rituximab/Vincristine
- (UMLS (NCI) C1328000) =Therapeutic or Preventive Procedure ;
|
- 8324. Cyclohexanecarboxylic Acid, 4-(aminomethyl)-, trans-
- [A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action. ( NCI )] (UMLS (NCI) C0040613) =Organic Chemical; Pharmacologic Substance ;
=Cyclohexanecarboxylic Acids;
[BL300] ANTIHEMORRHAGICS =TRANEXAMIC ACID PWDR;
TRANEXAMIC ACID 100 MG/ML;
TRANEXAMIC ACID 500 MG | - 8374. Cyclophosphamide/Doxorubicin/Tipifarnib
- (UMLS (NCI) C1327808) =Therapeutic or Preventive Procedure ;
|
- 8325. cyclohexanone
- [cyclohexane ring substituted by one or more ketones in any position. ( CSP )] (UMLS (CSP) C0056760) =Organic Chemical ;
=cyclic ketone;
=KETAMINE | - 8375. Cyclophosphamide/Doxorubicin/Tirapazamine
- (UMLS (NCI) C1134499) =Therapeutic or Preventive Procedure
|
- 8326. cyclohexene carboxylate
- [ ] (UMLS (CSP) C0920450) =Organic Chemical
| - 8376. Cyclophosphamide/Epirubicin/Fluorouracil/Methotrexate
- (UMLS (NCI) C0796647) =Therapeutic or Preventive Procedure
|
- 8327. cycloheximide
- [antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus; it inhibits protein synthesis in eukaryotic cells by blocking translation of messenger RNA on the ribosome. ( CSP )] (UMLS (CSP) C0010572) =Organic Chemical; Antibiotic =antifungal antibiotic;
piperidine | - 8377. Cyclophosphamide/Epirubicin/Gemcitabine/Paclitaxel
- (UMLS (NCI) C1134683) =Therapeutic or Preventive Procedure
|
- 8328. cyclohexylamine
- [ ] (UMLS (CSP) C0010573) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
| - 8378. Cyclophosphamide/Epirubicin/Paclitaxel
- (UMLS (NCI) C1134684) =Therapeutic or Preventive Procedure
|
- 8329. Cyclomen
- (UMLS (NCI) C0813502) Danocrine;
Danol;
Ladogal =Steroid; Pharmacologic Substance ;
| - 8379. Cyclophosphamide/Etoposide/Imatinib Mesylate
- (UMLS (NCI) C1327818) =Therapeutic or Preventive Procedure ;
|
- 8330. cyclooxygenase inhibitor
- [compounds or agents that combine with cyclooxygenase (prostaglandin endoperoxide synthase) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. ( CSP )] (UMLS (CSP) C0085387) =Pharmacologic Substance =NSAIDs;
enzyme inhibitor;
oxidoreductase inhibitor;
=COX2 inhibitor;
1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid | - 8380. Cyclophosphamide/Etoposide/Imatinib Mesylate/Leucovorin Calcium/Methotrexate
- (UMLS (NCI) C1327868) =Therapeutic or Preventive Procedure ;
|
- 8331. cyclopentane
- [C5H10, colorless liquid, used as a solvent. ( CSP )] (UMLS (CSP) C0010580) =Organic Chemical ;
=Cycloparaffins;
cyclic compound =caramiphen;
carbetapentane | - 8381. Cyclophosphamide/Etoposide/Leucovorin Calcium/Methotrexate
- (UMLS (NCI) C1327867) =Therapeutic or Preventive Procedure
|
- 8332. CYCLOPENTOLATE
- [A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia. ( MSH )] (UMLS (NCI) C0010582) =Organic Chemical; Pharmacologic Substance =phenylacetate;
[OP600] MYDRIATICS/CYCLOPLEGICS, TOPICAL OPHTHALMIC =CYCLOPENTOLATE HYDROCHLORIDE;
| - 8382. Cyclophosphamide/Etoposide/Prednisone
- (UMLS (NCI) C1327752) =Therapeutic or Preventive Procedure ;
|
- 8333. cyclophilin
- [catalyses one step in the refolding of urea denatured ribonuclease A enzyme is identical to the protein which binds the immunosuppressive drug cyclosporin. ( CSP )] (UMLS (CSP) C0136073) =Amino Acid, Peptide, or Protein; Enzyme ;
=isomerase;
| - 8383. Cyclophosphamide/Filgrastim/Rituximab
- (UMLS (NCI) C1328070) =Therapeutic or Preventive Procedure; ;
|
- 8334. CYCLOPHORIA
- [ ] (UMLS (ICD9CM) C0152219) =Sign or Symptom ;
| - 8384. Cyclophosphamide/Fludarabine/Melphalan
- (UMLS (NCI) C1327796) =Therapeutic or Preventive Procedure ;
|
- 8335. Cyclophosphamide/Cyclosporine/Fludarabine/Methylprednisolone/Thiotepa
- (UMLS (NCI) C1328015) =Therapeutic or Preventive Procedure ;
| - 8385. Cyclophosphamide/Fludarabine/Oblimersen
- (UMLS (NCI) C1134472) =Therapeutic or Preventive Procedure
|
- 8336. Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Pegaspargase/Thioguanine/Vincristine
- (UMLS (NCI) C1327984) =Therapeutic or Preventive Procedure ;
| - 8386. Cyclophosphamide/Fludarabine/Rituximab
- (UMLS (NCI) C1327865) =Therapeutic or Preventive Procedure
|
- 8337. Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Filgrastim/Leucovorin Calcium/Methotrexate/Rituximab/Vincristine
- (UMLS (NCI) C1134673) =Therapeutic or Preventive Procedure
| - 8387. Cyclophosphamide/Fluorouracil/Methotrexate/Trastuzumab
- (UMLS (NCI) C1134648) =Therapeutic or Preventive Procedure
|
- 8338. Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Thioguanine/Vincristine
- (UMLS (NCI) C1134445) =Therapeutic or Preventive Procedure ;
| - 8388. Cyclophosphamide/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0879562) =Therapeutic or Preventive Procedure
|
- 8339. Cyclophosphamide/Cytarabine/Dexamethasone/Etoposide Phosphate/Methotrexate
- (UMLS (NCI) C1328103) =Therapeutic or Preventive Procedure; ;
| - 8389. Cyclophosphamide/Methylprednisolone/Rasburicase/Vincristine
- (UMLS (NCI) C1327934) =Therapeutic or Preventive Procedure; ;
|
- 8340. Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate
- (UMLS (NCI) C0935860) =Therapeutic or Preventive Procedure
| - 8390. Cyclophosphamide/Methylprednisolone/Rituximab
- (UMLS (NCI) C1328013) =Therapeutic or Preventive Procedure ;
|
- 8341. Cyclophosphamide/Cytarabine/Dexamethasone/Mitoxantrone
- (UMLS (NCI) C0879546) =Therapeutic or Preventive Procedure ;
| - 8391. Cyclophosphamide/Oblimersen
- (UMLS (NCI) C1327956) =Therapeutic or Preventive Procedure; ;
|
- 8342. Cyclophosphamide/Cytarabine/Fludarabine
- (UMLS (NCI) C0879376) =Therapeutic or Preventive Procedure
| - 8392. Cyclophosphamide/Pentostatin/Rituximab
- (UMLS (NCI) C1134660) =Therapeutic or Preventive Procedure
|
- 8343. Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0879561) =Therapeutic or Preventive Procedure
| - 8393. Cyclophosphamide/Prednisone/Rasburicase/Vincristine
- (UMLS (NCI) C1327933) =Therapeutic or Preventive Procedure; ;
|
- 8344. Cyclophosphamide/cytarabine/mercaptopurine/methotrexate/prednisolone
- (UMLS (NCI) C0935859) =Therapeutic or Preventive Procedure
| - 8394. Cyclophosphamide/Prednisone/Rituximab
- (UMLS (NCI) C1328014) =Therapeutic or Preventive Procedure ;
|
- 8345. Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Prednisone
- (UMLS (NCI) C0879409) =Therapeutic or Preventive Procedure
| - 8395. CYCLOPHOTOCOAGULATION
- [ ] (UMLS (ICD9CM) C0395490) =Therapeutic or Preventive Procedure
|
- 8346. Cyclophosphamide/Cytarabine/Topotecan
- (UMLS (NCI) C0879588) =Therapeutic or Preventive Procedure
| - 8396. cycloplegic
- [ ] (UMLS (CSP) C0010586) =Pharmacologic Substance ;
|
- 8347. Cyclophosphamide/Dactinomycin/Irinotecan/Vincristine
- (UMLS (NCI) C1328054) =Therapeutic or Preventive Procedure ;
| - 8397. cyclopropane
- [C3H6; a flammable moderately toxic narcotic colorless gas used in organic synthesis and as an anesthetic. ( CSP )] (UMLS (CSP) C0010587) =Organic Chemical; Pharmacologic Substance =cyclic compound;
|
- 8348. Cyclophosphamide/Daunorubicin/Dexamethasone/Imatinib Mesylate/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C1134459) =Therapeutic or Preventive Procedure ;
| - 8398. Cyclopropaneacetic Acid, 1-((((1R)-1-(3-((1E)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, Monosodium Salt
- [The monosodium salt of montelukast, a selective and orally active leukotriene receptor antagonist with anti-inflammatory and bronchodilator activity. Montelukast sodium selectively and competitively blocks the cysteinyl leukotriene 1 (CysLT1) receptor, thereby preventing leukotriene D4 from binding to its receptor. This prevents leukotriene-mediated activities, including enhanced migration of eosinophils and neutrophils, increased adhesion of leukocytes, increased monocyte and neutrophil aggregation, increased airway edema, increased capillary permeability and bronchoconstriction. ( NCI )] (UMLS (NCI) C0380447) =Organic Chemical; Pharmacologic Substance ;
=MONTELUKAST;
=MONTELUKAST SODIUM 10 MG;
MONTELUKAST SODIUM 5 MG;
MONTELUKAST SODIUM 4 MG;
|
- 8349. Cyclophosphamide/Decitabine/Doxorubicin
- (UMLS (NCI) C1328118) =Therapeutic or Preventive Procedure; ;
| - 8399. cyclopropene
- [ ] (UMLS (CSP) C0056811) =Organic Chemical ;
|
- 8350. Cyclophosphamide/Detox-B Adjuvant/Interleukin-2
- (UMLS (NCI) C0935655) =Therapeutic or Preventive Procedure
| - 8400. cyclosarin
- [ ] (UMLS (CSP) C0164843) =Organic Chemical; Hazardous or Poisonous Substance ;
|
home
